Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells

Journal of Virological Methods

Volumn 90, Issue 2, 2000, Pages 193-204

  Meij, Pauline ^a   Vervoort, Marcel B H J ^a   Meijer, Chris J L M ^a   Bloemena, Elisabeth ^a   Middeldorp, Jaap M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Baculovirus; Epstein Barr virus; Latent membrane protein 1; Purification

Indexed keywords

LATENT MEMBRANE PROTEIN 1; VIRUS PROTEIN;

ANIMAL CELL; ANTIBODY AFFINITY; ARTICLE; BACULOVIRUS; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FREEZE DRYING; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SUPERNATANT; VIRUS CHARACTERIZATION; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BACULOVIRIDAE; CALLITHRIX; CELL LINE; CELL LINE, TRANSFORMED; CHROMATOGRAPHY, AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; INSECTS; ONCOGENE PROTEINS, VIRAL; RECOMBINANT PROTEINS; SEPHAROSE; TRANSFECTION; VIRAL MATRIX PROTEINS;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4; INSECTA; UNIDENTIFIED BACULOVIRUS;

EID: 0033734837     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(00)00233-0     Document Type: Article

References (30)

1. Catalyzed reporter deposition, a novel method of signal amplification. I. Application to immunoassays
2. Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays
3. Presence or Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas
4. Expression of the Epstein-Barr virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera against this protein
5. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1
6. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines
7. Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus
8. The A20 protein interacts with Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex
9. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
10. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-(B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain
11. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): Evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP-specific cytotoxic T lymphocytes
12. Epstein-Barr virus and its replication
13. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice
14. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B
15. An Epstein-Barr virus transforming protein associates with vimetin in lymphocytes
16. Continuous production of baculovirus in a cascade of insect-cell reactors
17. Improving structural integrity of cryosections for immunogold labeling
18. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases
19. Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides
20. Silver stain for proteins in polyacrylamide gel: A modified procedure with enhanced uniform sensitivity
21. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 in Burkitt lymphoma lines
22. Epstein-Barr virus and gastric carcinoma
23. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukaemia cells, T cells, and hematopoietic cell lines: Cell-type-independent-induction of CD23, CD21, and ICAM-1
24. One-step immunoaffinty purification of recombinant human retinoic acid receptor gamma
25. Epstein-Barr virus
26. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: Implications for immune-mediated therapy of EBV+Hodgkin's disease
27. Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR
28. An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA
29. An EBV membrane protein expressed in immortalised lymphocytes transforms established rodent cells
30. Expression of the Epstein-Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines